Stock OLMA OLEMA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Olema Pharmaceuticals, Inc.

Equities

OLMA

US68062P1066

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
9.95 USD +1.22% Intraday chart for Olema Pharmaceuticals, Inc. +0.20% -29.08%
Apr. 02 Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target MT
Mar. 18 Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to S&P Biotechnology Select Industry Index CI

Evolution of the average Target Price on Olema Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

dbc74725f95b09e728c0890.tkJTNRq5GmYS9JArHFncw53YsXueaBOl-0ZqEA52SRw.jw1kemrpVhN3m6BjZmCfsfy8iQGzCWLnzzcNIFdOBy_xCxhiW8tOM2ix5w~5949d4db79d57d44ec17d473f942b8f6

Analyst Recommendations on Olema Pharmaceuticals, Inc.

Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target MT
HC Wainwright Adjusts Price Target on Olema Pharmaceuticals to $25 From $28, Maintains Buy Rating MT
Citigroup Initiates Olema Pharmaceuticals at Buy With $20 Price Target MT
JPMorgan Adjusts Olema Pharmaceuticals' Price Target to $25 From $19, Maintains Overweight Rating MT
Canaccord Genuity Adjusts Olema Pharmaceuticals' Price Target to $22 From $16, Maintains Buy Rating MT
JPMorgan Adjusts Price Target on Olema Pharmaceuticals to $19 From $16, Maintains Overweight Rating MT
Credit Suisse Adjusts Olema Pharmaceuticals' Price Target to $18 From $16, Keeps Outperform Rating MT
HC Wainwright Adjusts Price Target on Olema Pharmaceuticals to $22 From $17, Maintains Buy Rating MT
Oppenheimer Initiates Coverage on Olema Pharmaceuticals With Outperform Rating, $21 Price Target MT
HC Wainwright Adjusts Price Target on Olema Pharmaceuticals to $15 From $12, Keeps Buy Rating MT
Credit Suisse Lowers Olema Pharmaceuticals' Price Target to $11 From $12, Keeps Outperform Rating MT
Canaccord Genuity Assumes Olema Pharmaceuticals Inc at Buy with $16 Price Target MT
HC Wainwright Upgrades Olema Pharmaceuticals to Buy From Neutral, Sets $12 Price Target MT
HC Wainwright Starts Olema Pharmaceuticals at Neutral MT
OLEMA PHARMACEUTICALS : Canaccord Genuity Initiates Coverage on Olema Pharmaceuticals With Buy Rating, $60 Price Target MT
OLEMA PHARMACEUTICALS : Jefferies Starts Olema Pharmaceuticals at Buy with $70 Price Target MT
OLEMA PHARMACEUTICALS : JP Morgan Starts Olema Pharmaceuticals at Overweight with $52 Price Target MT
OLEMA PHARMACEUTICALS : Cowen Starts Olema Pharmaceuticals at Outperform MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
9.95 USD
Average target price
25 USD
Spread / Average Target
+151.26%
High Price Target
32 USD
Spread / Highest target
+221.61%
Low Price Target
20 USD
Spread / Lowest Target
+101.01%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Olema Pharmaceuticals, Inc.

Goldman Sachs
HC Wainwright
Citigroup
JPMorgan Chase
Canaccord Genuity
Credit Suisse
Oppenheimer

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. OLMA Stock
  4. Consensus Olema Pharmaceuticals, Inc.